Stay updated with breaking news from Newell rogers. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
GLOBAL CANCER TECHNOLOGY RECEIVES INITIAL PRE-CLINICAL RESULTS OF GCT-007 IN PSORIASIS menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
Global Cancer Technology Licenses Biomarker Technology from Baylor Scott & White Research Institute to Support Research Efforts Towards Treatment for Glioblastoma prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Published: Jun 03, 2021 By Alex Keown 180 Life Sciences Russell T. Ray and Teresa DeLuca were appointed to the board of directors of 180 Life Sciences. Ray was formerly Managing Director and co-Head of Global Health Care at Credit Suisse First Boston Corporation. More recently, Ray was a Partner and Senior Advisor to HLM Venture Partners, a health care-focused venture capital firm. He currently serves on the board of directors of Merrimack Pharmaceuticals, Inc. DeLuca comes to 180 Life Sciences as both a public independent board director and former senior executive Chief Medical Officer. Her most recent role was at Columbia University as Managing Director of NY Life Science Venture Fund. ....
/PRNewswire/ Global Cancer Technology the cancer research company using invisible dots to solve visible problems in healthcare today announced the. ....